Robust physiologically based pharmacokinetic model of rifampicin for predicting drug-drug interactions via P-glycoprotein induction and inhibition in the intestine, liver, and kidney - Asaumi, R; Nunoya, K.ichi; Yamaura, Y; Taskar, KS; Sugiyama, Y. (CPT Pharmacometrics Syst. Pharmacol., no. April, 2022)